Healthcare Intelligence
Oncology
Real-time intelligence, expert analysis, and verified research for the Oncology industry. Stay ahead in 3 minutes a day.
Stay ahead of Oncology in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
FDA Approves Novartis' Scemblix for Newly Diagnosed CML Patients
FDA grants approval for Scemblix as first-line treatment for chronic myeloid leukemia, offering new option for newly diagnosed patients.
Read full articleMerck's Keytruda Shows Promise in Early-Stage Lung Cancer Trial
Phase 3 trial data shows Keytruda significantly improves disease-free survival in early-stage non-small cell lung cancer patients.
Read full articleBioNTech Partners with Genentech for $1.8B mRNA Cancer Vaccine Deal
BioNTech and Genentech collaborate on personalized mRNA cancer vaccines, with Genentech paying $1.8 billion upfront and milestones.
Read full articleAI System Outperforms Radiologists in Breast Cancer Detection Study
Google Health's AI model achieves 94% accuracy in detecting breast cancer from mammograms, surpassing human radiologist performance.
Read full articlePfizer Halts Late-Stage Trial of Experimental Ovarian Cancer Drug
Pfizer discontinues Phase 3 trial after interim analysis shows drug unlikely to meet primary endpoints for overall survival.
Read full articleCAR-T Therapy Shows 89% Response Rate in Multiple Myeloma Trial
Johnson & Johnson's CAR-T therapy demonstrates high response rates in heavily pretreated multiple myeloma patients in pivotal trial.
Read full articleEuropean Regulators Approve First CRISPR Cancer Treatment
EMA approves CRISPR Therapeutics' gene-editing therapy for treating certain blood cancers, marking milestone for gene editing.
Read full articleAstraZeneca's ADC Drug Extends Survival in Metastatic Breast Cancer
New antibody-drug conjugate shows 35% reduction in death risk for HER2-low metastatic breast cancer patients versus chemotherapy.
Read full articleFDA Approves Novartis' Scemblix for Newly Diagnosed CML Patients
FDA grants approval for Scemblix as first-line treatment for chronic myeloid leukemia, offering new option for newly diagnosed patients.
Read full articleMerck's Keytruda Shows Promise in Early-Stage Lung Cancer Trial
Phase 3 trial data shows Keytruda significantly improves disease-free survival in early-stage non-small cell lung cancer patients.
Read full articleBioNTech Partners with Genentech for $1.8B mRNA Cancer Vaccine Deal
BioNTech and Genentech collaborate on personalized mRNA cancer vaccines, with Genentech paying $1.8 billion upfront and milestones.
Read full articleAI System Outperforms Radiologists in Breast Cancer Detection Study
Google Health's AI model achieves 94% accuracy in detecting breast cancer from mammograms, surpassing human radiologist performance.
Read full articlePfizer Halts Late-Stage Trial of Experimental Ovarian Cancer Drug
Pfizer discontinues Phase 3 trial after interim analysis shows drug unlikely to meet primary endpoints for overall survival.
Read full articleCAR-T Therapy Shows 89% Response Rate in Multiple Myeloma Trial
Johnson & Johnson's CAR-T therapy demonstrates high response rates in heavily pretreated multiple myeloma patients in pivotal trial.
Read full articleEuropean Regulators Approve First CRISPR Cancer Treatment
EMA approves CRISPR Therapeutics' gene-editing therapy for treating certain blood cancers, marking milestone for gene editing.
Read full articleAstraZeneca's ADC Drug Extends Survival in Metastatic Breast Cancer
New antibody-drug conjugate shows 35% reduction in death risk for HER2-low metastatic breast cancer patients versus chemotherapy.
Read full articleStay ahead of Oncology in 3 minutes a day.
Live industry forecasting for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.